ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Lung transplantation"

  • 2021 American Transplant Congress

    Bilateral Lung Transplantation for Destroyed Lungs with Asymmetric Thorax

    B. Yue, J. Chen

    Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, China

    *Purpose: Destroyed lungs can cause mediastinal displacement, asymmetric chest deformity, and high risk and difficulty of surgery. Until now, there are few reports about bilateral…
  • 2021 American Transplant Congress

    Perioperative Blood Transfusion is Associated with the Development of New HLA Antibodies After Adult Lung Transplantation

    A. Hicks1, A. Stoker2, M. Cooter2, A. Ali3, J. Klapper4, J. Poisson5, D. Chen5, J. Haney4, K. Ghadimi2, M. Hartwig4, I. Welsby2, B. Bottiger2

    1Anesthesiology, Duke University Hospital, South Portland, ME, 2Anesthesiology, Duke University Hospital, Durham, NC, 3Pulmonology, Allergy and Critical Care Medicine, Duke University Hospital, Durham, NC, 4Cardiothoracic Surgery, Duke University Hospital, Durham, NC, 5Pathology, Duke University Hospital, Durham, NC

    *Purpose: Lung transplant (LT) recipients who develop new antibodies to human leukocyte antigen (HLA) have associated with chronic lung allograft dysfunction and worsened outcomes. We…
  • 2021 American Transplant Congress

    Randomized Phase 3 Open-label Study of Maribavir vs Investigator-assigned Therapy for Refractory/resistant Cytomegalovirus Infection in Transplant Recipients: Subgroup Analyses of Efficacy by Organ

    R. K. Avery1, E. A. Blumberg2, D. Florescu3, N. Kamar4, D. Kumar5, J. Wu6, A. Sundberg6

    1Johns Hopkins Hospital, Baltimore, MD, 2University of Pennsylvania, Philadelphia, PA, 3University of Nebraska School of Medicine, Omaha, NE, 4Hôpital de Rangueil, Toulouse, France, 5University Health Network, Toronto, ON, Canada, 6Shire Human Genetic Therapies, Inc., a Takeda company, Lexington, KY

    *Purpose: Therapeutic options for refractory, with/without resistance (R/R), CMV infections are limited. We report organ type subgroup analyses from a large multi-center trial that studied…
  • 2021 American Transplant Congress

    Long-Term Renal Outcomes in Lung Transplant Recipients- A Single-Center Five-Year Experience

    M. Doraiswamy, E. Obole, P. Singh, T. Pesavento

    Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH

    *Purpose: The increased longevity in Lung transplant (LTx) has led to an upsurge in chronic medical comorbidities, including Acute kidney injury (AKI), Chronic kidney disease…
  • 2021 American Transplant Congress

    Incidentally Detected Malignancies in Lung Explants: Single Center Case Series

    D. Razia, A. Arjuna, L. Schaheen, J. Huang, M. Smith, R. Bremner, R. Walia

    Thoracic Surgery and Lung Transplantation, Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ

    *Purpose: Thoracic malignancies are difficult to prospectively diagnose in patients with end-stage lung disease due to complex radiologic features. We present a series of lung…
  • 2021 American Transplant Congress

    A Randomized, Multicenter, Blinded Study Assessing the Effects of Gaseous Nitric Oxide in an Ex Vivo System of Human Lungs

    M. G. Hartwig1, J. A. Klapper1, N. Poola2, A. Banga3, P. G. Sanchez4, J. S. Murala3, J. L. Potenziano2

    1Duke University Medical Center, Durham, NC, 2Mallinckrodt Pharmaceuticals, Bedminster, NJ, 3University of Texas Southwestern Medical Center, Dallas, TX, 4University of Pittsburgh Medical Center, Pittsburgh, PA

    *Purpose: The effects of nitric oxide (NO) on donor lungs during ex vivo lung perfusion (EVLP) have not been studied. We assessed whether the novel…
  • 2021 American Transplant Congress

    Alpha 1-antitrypsin Reduces Cytokine Elaboration in a Xenogeneic Lung Transplantation Model

    L. Burdorf1, C. Laird2, T. Zhang2, M. R. Connolly1, Z. Habibabady1, S. Pratts1, S. Miura1, F. Pollok1, W. Eyestone3, C. J. Phelps3, D. L. Ayares3, A. M. Azimzadeh1, R. N. Pierson III1

    1Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Surgery, University of Maryland, Baltimore, MD, 3Revivicor, Blacksburg, VA

    *Purpose: Novel gene editing techniques have facilitated the generation of donor pigs with multiple genetic modifications, used for xenolung transplantation. Several rejection pathways, including antibody…
  • 2021 American Transplant Congress

    A Case-Match Cohort Comparison of the Safety and Efficacy of Basiliximab for Immunosuppression Holiday in Lung Transplant Patients

    M. M. Eiting1, J. E. Clark1, T. L. Astor2, J. Palafox2, C. Rogers Marks1, G. Waldman1

    1Pharmacy, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA

    *Purpose: Post-transplant complications related to calcineurin inhibitors (CNI) maintenance immunosuppression (MI) may require interim alternative therapies. The goal of this study is to evaluate the…
  • 2021 American Transplant Congress

    Accounting for Survivor Bias in Transplant Benefit Models

    E. M. Schnellinger1, E. Cantu2, M. O. Harhay1, D. E. Schaubel1, S. E. Kimmel1, A. J. Stephens-Shields1

    1Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2Department of Surgery, Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: The lung allocation system in the U.S. prioritizes lung transplant candidates based on estimated pre- and post-transplant survival. However, these models do not account…
  • 2021 American Transplant Congress

    Pregnancy Outcomes in 39 Lung Transplant Recipients

    S. Constantinescu1, L. A. Coscia2, A. Yusuf2, S. Rao3, M. J. Moritz4

    1Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 2Transplant Pregnancy Registry International, Philadelphia, PA, 3University of Virginia Heath System, Charlottesville, VA, 4Lehigh Valley Health Network, Allentown, PA

    *Purpose: The purpose of this study is to describe 52 pregnancies in 39 lung transplant recipients reporting to the Transplant Pregnancy Registry International (TPRI) from…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences